Allofit® IT With HXPE in Total Hip Arthroplasty
← catalyst calendarSponsored by Zimmer Biomet (industry) · ZBH — their whole pipeline →.
Phase
—
Status
Completed
Study type
Observational
Enrollment
197actual
Sites
5
Countries
Austria, France, Germany +1
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2011-06-05 | actual | When the study began enrolling |
| Primary completion | 2025-07-03 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2025-07-03 | actual | The whole study's end, after follow-up |
| First posted | 2018-09-17 | actual | When this record first appeared on the registry |
| Results posted | 2026-01-27 | actual | When the sponsor posted results to the registry |
| Record updated | 2026-01-27 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Conditions
- Avascular Necrosis
- Osteoarthritis, Hip
- Inflammatory Arthritis
- Post-Traumatic Osteoarthritis of Hip
Primary outcome
what the primary-completion date above is the date OFSurvival of the Implant System
measured 10 years post-surgery
Posted documents
hosted by the registry — we link, never re-serveStudy Protocol, Statistical Analysis Plan, and Informed Consent Formposted 2011-02-02 · 1.3 MB · Prot_SAP_ICF_000.pdf
Permalink · ZBH's whole pipeline · Catalyst calendar · Every registered study · What changed